Citations 0
Editor's Correspondence
December 9/23, 2002

Cyclooxygenase-2 Inhibitors and Myocardial Infarction

Author Affiliations

Copyright 2002 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2002

Arch Intern Med. 2002;162(22):2639. doi:

The findings from 3 case-control studies in a recent issue of the ARCHIVES13 do not eliminate the possibility that cyclooxygenase (COX)-2 inhibitors increase the risk of myocardial infarction (MI) and other thrombotic cardiovascular events by altering the balance between prostacyclin and thromboxane.4,5 The studies suggest that naproxen may modestly decrease the risk of MI.

First Page Preview View Large
First page PDF preview
First page PDF preview